Platform injectable gel based therapeutic for osteoarthritis
Knee osteoarthritis pain is progressive and often requires frequent injections and strong oral medications that can lead to opioid dependence.
An injectable therapeutic gel for knee osteoarthritis that selectively blocks pain-transmitting nerves and provides longer-lasting pain relief.
Patients with knee osteoarthritis treated by orthopedic, sports medicine, or pain management clinicians.
Alison is CEO and Founder at Relevium Medical. Alison holds qualifications in Chemistry and Biochemical Engineering (M.Sc. & Ph.D.). She has worked for major multinational companies including ROCHE, Cook Medical and Boston Scientific; and completed the BioInnovate Fellowship in the prestigious Stanford BioDesign-affiliated program at NUI Galway, Ireland. She is the named inventor on over 20 patent publications and the winner of the Science Foundation of Ireland’s €1 million innovation prize.



